ANDERSON ELIZABETH M 4

What Happened
Elizabeth M. Anderson, a director of BioMarin Pharmaceutical Inc. (BMRN), was awarded 7,490 restricted stock units on June 2, 2026. The award is reported as an acquisition (code A) at $0.00 per share because RSUs are grants rather than open-market purchases; no aggregate dollar sale/purchase value is shown.

Key Details

• Transaction date: 2026-06-02 (reported on Form 4 filed 2026-06-04). Filing appears timely (Form 4 is generally due within two business days).
• Transaction type/code: Award/grant (A).
• Shares granted: 7,490 restricted stock units (RSUs). Price per share: $0.00 (price not applicable).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: F1 — "Restricted stock units granted on June 2, 2026. Price not applicable."

Context
RSU grants are typically company compensation for executives or directors and do not represent an immediate open-market purchase or sale. They usually vest over time (vesting schedule and tax implications are detailed elsewhere) and therefore are not a direct signal of buying or selling activity.